Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Nov-24 4:05 PM View:  | Cislini Jeff General Counsel | Revolution Medicines, Inc. (RVMD) | 15-Nov-24 | Private Sale (Planned) | 2,554 | $55.13 | $140,811.00 | (6%) 45.63K to 43.08K | |
| 15-Nov-24 4:08 PM View: | Kelsey Stephen Michael See Remarks | Revolution Medicines, Inc. (RVMD) | 13-Nov-24 | Option Exercise | 16,666 | $4.09 | $68,163.90 | 6% 264.41K to 281.07K | |
| 15-Nov-24 4:08 PM View: | Kelsey Stephen Michael See Remarks | Revolution Medicines, Inc. (RVMD) | 13-Nov-24 | Planned Option Sale | 16,666 | $58.65 | $977,509.00 | (6%) 281.07K to 264.41K | |
| 15-Oct-24 5:29 PM View: | Cislini Jeff General Counsel | Revolution Medicines, Inc. (RVMD) | 11-Oct-24 | Planned Option Sale | 6,000 | $50.17 | $301,027.00 | (12%) 51.63K to 45.63K | |
| 15-Oct-24 5:30 PM View: | Goldsmith Mark A See Remarks Director | Revolution Medicines, Inc. (RVMD) | 11-Oct-24 | Option Exercise | 30,000 | $4.09 | $122,700.00 | 4% 816.62K to 846.62K | |
| 15-Oct-24 5:30 PM View: | Goldsmith Mark A See Remarks Director | Revolution Medicines, Inc. (RVMD) | 11-Oct-24 | Planned Option Sale | 30,000 | $50.36 | $1,510,770.00 | (4%) 846.62K to 816.62K | |
| 15-Oct-24 5:31 PM View: | Horn Margaret A Chief Operating Officer | Revolution Medicines, Inc. (RVMD) | 11-Oct-24 | Planned Option Sale | 50,000 | $50.34 | $2,517,060.00 | (27%) 182.32K to 132.32K | |
| 15-Oct-24 5:29 PM View: | Cislini Jeff General Counsel | Revolution Medicines, Inc. (RVMD) | 11-Oct-24 | Option Exercise | 6,000 | $36.57 | $219,420.00 | 13% 45.63K to 51.63K | |
| 15-Oct-24 5:30 PM View: | Anders Jack Chief Financial Officer | Revolution Medicines, Inc. (RVMD) | 11-Oct-24 | Planned Option Sale | 10,000 | $50.30 | $502,979.00 | (9%) 108.93K to 98.93K | |
| 15-Oct-24 5:31 PM View: | Horn Margaret A Chief Operating Officer | Revolution Medicines, Inc. (RVMD) | 11-Oct-24 | Option Exercise | 50,000 | $4.09 | $204,500.00 | 38% 132.32K to 182.32K | |
| 15-Oct-24 5:30 PM View: | Anders Jack Chief Financial Officer | Revolution Medicines, Inc. (RVMD) | 11-Oct-24 | Option Exercise | 10,000 | $2.68 | $26,800.00 | 10% 98.93K to 108.93K | |
| 10-Oct-24 4:16 PM View: | Weber Barbara Director | Revolution Medicines, Inc. (RVMD) | 08-Oct-24 | Private Sale (Planned) | 5,200 | $48.02 | $249,716.00 | (28%) 18.27K to 13.06K | |
| 03-Oct-24 4:33 PM View: | Goldsmith Mark A See Remarks Director | Revolution Medicines, Inc. (RVMD) | 01-Oct-24 | Option Exercise | 10,000 | $4.09 | $40,900.00 | 1% 816.62K to 826.62K | |
| 03-Oct-24 4:33 PM View: | Goldsmith Mark A See Remarks Director | Revolution Medicines, Inc. (RVMD) | 01-Oct-24 | Planned Option Sale | 10,000 | $44.93 | $449,322.00 | (1%) 826.62K to 816.62K | |
| 18-Sep-24 4:17 PM View: | Horn Margaret A Chief Operating Officer | Revolution Medicines, Inc. (RVMD) | 16-Sep-24 | Private Sale (Planned) | 4,331 | $44.19 | $191,367.00 | (3%) 136.65K to 132.32K | |
| 18-Sep-24 4:17 PM View: | Kelsey Stephen Michael See Remarks | Revolution Medicines, Inc. (RVMD) | 16-Sep-24 | Private Sale (Planned) | 4,665 | $44.19 | $206,124.00 | (2%) 269.07K to 264.41K | |
| 18-Sep-24 4:18 PM View: | Anders Jack Chief Financial Officer | Revolution Medicines, Inc. (RVMD) | 16-Sep-24 | Private Sale (Planned) | 2,244 | $44.19 | $99,151.80 | (2%) 101.18K to 98.93K | |
| 18-Sep-24 4:18 PM View: | Goldsmith Mark A See Remarks Director | Revolution Medicines, Inc. (RVMD) | 16-Sep-24 | Private Sale (Planned) | 11,715 | $44.19 | $517,631.00 | (1%) 828.34K to 816.62K | |
| 18-Sep-24 4:16 PM View: | Cislini Jeff General Counsel | Revolution Medicines, Inc. (RVMD) | 16-Sep-24 | Private Sale (Planned) | 1,454 | $44.19 | $64,245.40 | (3%) 47.09K to 45.63K | |
| 16-Sep-24 4:05 PM View: | Kelsey Stephen Michael See Remarks | Revolution Medicines, Inc. (RVMD) | 13-Sep-24 | Option Exercise | 16,667 | $4.09 | $68,168.00 | 6% 269.07K to 285.74K | |
| 16-Sep-24 4:05 PM View: | Kelsey Stephen Michael See Remarks | Revolution Medicines, Inc. (RVMD) | 13-Sep-24 | Planned Option Sale | 16,667 | $43.32 | $722,088.00 | (6%) 285.74K to 269.07K | |
| 23-Aug-24 4:15 PM View: | Weber Barbara Director | Revolution Medicines, Inc. (RVMD) | 21-Aug-24 | Disposition | 1,808 | $44.83 | $81,052.60 | (9%) 20.07K to 18.27K | |
| 15-Aug-24 4:48 PM View: | Kelsey Stephen Michael See Remarks | Revolution Medicines, Inc. (RVMD) | 13-Aug-24 | Planned Option Sale | 16,667 | $42.98 | $716,389.00 | (6%) 285.74K to 269.07K | |
| 15-Aug-24 4:48 PM View: | Kelsey Stephen Michael See Remarks | Revolution Medicines, Inc. (RVMD) | 13-Aug-24 | Option Exercise | 16,667 | $4.09 | $68,168.00 | 6% 269.07K to 285.74K | |
| 07-Aug-24 5:34 PM View: | Clyburn Frank Director | Revolution Medicines, Inc. (RVMD) | 05-Aug-24 | Grant | 6,932 | -- | -- | 100% 0 to 6.93K | |
| 02-Aug-24 5:35 PM View: | Goldsmith Mark A See Remarks Director | Revolution Medicines, Inc. (RVMD) | 01-Aug-24 | Planned Option Sale | 10,000 | $45.88 | $458,827.00 | (1%) 838.34K to 828.34K | |
| 02-Aug-24 5:35 PM View: | Goldsmith Mark A See Remarks Director | Revolution Medicines, Inc. (RVMD) | 01-Aug-24 | Option Exercise | 10,000 | $4.09 | $40,900.00 | 1% 828.34K to 838.34K | |
| 17-Jul-24 10:00 PM View: | Kelsey Stephen Michael See Remarks | Revolution Medicines, Inc. (RVMD) | 15-Jul-24 | Option Exercise | 16,667 | $4.09 | $68,168.00 | 6% 269.07K to 285.74K | |
| 17-Jul-24 10:00 PM View: | Kelsey Stephen Michael See Remarks | Revolution Medicines, Inc. (RVMD) | 15-Jul-24 | Planned Option Sale | 16,667 | $46.47 | $774,516.00 | (6%) 285.74K to 269.07K | |
| 16-Jul-24 5:05 PM View: | Goldsmith Mark A See Remarks Director | Revolution Medicines, Inc. (RVMD) | 12-Jul-24 | Sale (Planned) | 10,000 | $45.01 | $450,117.00 | (1%) 838.34K to 828.34K | |
| 16-Jul-24 5:05 PM View: | Goldsmith Mark A See Remarks Director | Revolution Medicines, Inc. (RVMD) | 12-Jul-24 | Option Exercise | 25,000 | $4.09 | $102,250.00 | 3% 838.34K to 863.34K | |
| 16-Jul-24 5:05 PM View: | Goldsmith Mark A See Remarks Director | Revolution Medicines, Inc. (RVMD) | 12-Jul-24 | Planned Option Sale | 25,000 | $45.05 | $1,126,200.00 | (3%) 863.34K to 838.34K | |
| 10-Jul-24 4:36 PM View: | Cislini Jeff General Counsel | Revolution Medicines, Inc. (RVMD) | 09-Jul-24 | Private Sale (Planned) | 2,399 | $40.83 | $97,951.20 | (5%) 49.49K to 47.09K | |
| 10-Jul-24 4:36 PM View: | Patel Sushil Director | Revolution Medicines, Inc. (RVMD) | 09-Jul-24 | Option Exercise | 2,155 | $16.80 | $36,204.00 | 11% 19.95K to 22.1K | |
| 10-Jul-24 4:36 PM View: | Patel Sushil Director | Revolution Medicines, Inc. (RVMD) | 09-Jul-24 | Planned Option Sale | 2,155 | $44.00 | $94,820.00 | (10%) 22.1K to 19.95K | |
| 27-Jun-24 6:48 PM View: | Cislini Jeff General Counsel | Revolution Medicines, Inc. (RVMD) | 26-Jun-24 | Private Sale (Planned) | 2,000 | $38.47 | $76,939.60 | (4%) 51.49K to 49.49K | |
| 26-Jun-24 4:26 PM View: | Kelsey Stephen Michael See Remarks | Revolution Medicines, Inc. (RVMD) | 25-Jun-24 | Planned Option Sale | 16,467 | $39.06 | $643,152.00 | (6%) 285.54K to 269.07K | |
| 26-Jun-24 4:26 PM View: | Kelsey Stephen Michael See Remarks | Revolution Medicines, Inc. (RVMD) | 25-Jun-24 | Option Exercise | 16,467 | $4.09 | $67,350.00 | 6% 269.07K to 285.54K | |
| 26-Jun-24 4:26 PM View: | Kelsey Stephen Michael See Remarks | Revolution Medicines, Inc. (RVMD) | 24-Jun-24 | Planned Option Sale | 200 | $39.00 | $7,800.00 | (< 1%) 269.27K to 269.07K | |
| 26-Jun-24 4:26 PM View: | Kelsey Stephen Michael See Remarks | Revolution Medicines, Inc. (RVMD) | 24-Jun-24 | Option Exercise | 200 | $4.09 | $818.00 | < 1% 269.07K to 269.27K | |
| 24-Jun-24 4:20 PM View: | Anderson Elizabeth M Director | Revolution Medicines, Inc. (RVMD) | 20-Jun-24 | Grant | 4,800 | -- | -- | 11% 42.81K to 47.62K | |
| 24-Jun-24 4:20 PM View: | Borellini Flavia Director | Revolution Medicines, Inc. (RVMD) | 20-Jun-24 | Grant | 4,800 | -- | -- | 27% 17.63K to 22.43K | |
| 24-Jun-24 4:20 PM View: | Weber Barbara Director | Revolution Medicines, Inc. (RVMD) | 20-Jun-24 | Grant | 4,800 | -- | -- | 30% 15.82K to 20.63K | |
| 24-Jun-24 4:21 PM View: | Kim Lorence H. Director | Revolution Medicines, Inc. (RVMD) | 20-Jun-24 | Grant | 4,800 | -- | -- | 7% 65.7K to 70.5K | |
| 20-Jun-24 4:10 PM View: | Wei Lin Chief Medical Officer | Revolution Medicines, Inc. (RVMD) | 17-Jun-24 | Private Sale | 5,589 | $37.39 | $208,954.00 | (7%) 76.44K to 70.85K | |
| 20-Jun-24 4:12 PM View: | Horn Margaret A Chief Operating Officer | Revolution Medicines, Inc. (RVMD) | 17-Jun-24 | Private Sale (Planned) | 4,415 | $37.39 | $165,064.00 | (3%) 141.07K to 136.65K | |
| 20-Jun-24 4:11 PM View: | Cislini Jeff General Counsel | Revolution Medicines, Inc. (RVMD) | 17-Jun-24 | Private Sale (Planned) | 1,757 | $37.39 | $65,689.70 | (3%) 53.24K to 51.49K | |
| 20-Jun-24 4:13 PM View: | Anders Jack Chief Financial Officer | Revolution Medicines, Inc. (RVMD) | 17-Jun-24 | Private Sale (Planned) | 1,893 | $37.39 | $70,774.70 | (2%) 103.07K to 101.18K | |
| 20-Jun-24 4:14 PM View: | Goldsmith Mark A See Remarks Director | Revolution Medicines, Inc. (RVMD) | 17-Jun-24 | Private Sale (Planned) | 11,950 | $37.39 | $446,770.00 | (1%) 850.29K to 838.34K | |
| 20-Jun-24 4:11 PM View: | Kelsey Stephen Michael See Remarks | Revolution Medicines, Inc. (RVMD) | 17-Jun-24 | Private Sale (Planned) | 3,349 | $37.39 | $125,209.00 | (1%) 272.42K to 269.07K |
